Pharmaceuticals
Medicaments, antibiotics, immunological products, dressings and bulk compounds from Thiruvananthapuram and Ernakulam.
How much of this sector enters duty-free
Share of the sector’s tariff lines in each FTA that are duty-free from day one, under a tariff rate quota, or excluded.
Products that benefit, and where they are made
22 products exported from Keralam that benefit across the FTAs, with their main production and export clusters.
| HS code | Product | Main production and export clusters |
|---|---|---|
| 300490 | Medicaments | Thiruvananthapuram, Thrissur |
| 300420 | Antibiotic medicaments | Thiruvananthapuram, Ernakulam |
| 300410 | Penicillin medicaments | Thiruvananthapuram, Ernakulam |
| 300450 | Vitamin medicaments | Thiruvananthapuram, Thrissur |
| 300390 | Other medicaments | Thiruvananthapuram, Ernakulam |
| 300590 | Medical dressings | Thiruvananthapuram, Ernakulam |
| 300215 | Immunological products | Thiruvananthapuram |
| 300214 | Immunological products | Thiruvananthapuram |
| 300431 | Insulin medicaments | Thiruvananthapuram |
| 300432 | Corticosteroid meds | Thiruvananthapuram, Ernakulam |
| 300439 | Hormone medicaments | Thiruvananthapuram, Ernakulam |
| 294190 | Antibiotics | Thiruvananthapuram, Ernakulam |
| 294200 | Organic compounds | Thiruvananthapuram, Ernakulam |
| 293339 | Heterocyclic compounds | Thiruvananthapuram, Ernakulam |
| 293359 | Pyrimidine compounds | Thiruvananthapuram, Ernakulam |
| 293499 | Nucleic acids | Thiruvananthapuram, Ernakulam |
| 293319 | Pyrazole compounds | Thiruvananthapuram, Ernakulam |
| 293329 | Imidazole compounds | Thiruvananthapuram, Ernakulam |
| 291815 | Citrate salts | Thiruvananthapuram, Ernakulam |
| 291811 | Lactic acid | Thiruvananthapuram, Ernakulam |
| 130219 | Herbal extracts | Idukki, Wayanad, Ernakulam |
| 293629 | Other vitamins | Thiruvananthapuram, Ernakulam |
Every product, every FTA market
Each cell shows the suggested category for a product in that market. Hover or tap a cell for the duty change and import demand.
| Product | HS | UK | EU | UAE | Oman | Australia | New Zealand | EFTA – Norway | EFTA – Switzerland | EFTA – Iceland |
|---|---|---|---|---|---|---|---|---|---|---|
| Medicaments | 300490 | III | III | III | III | III | III | III | III | III |
| Antibiotic medicaments | 300420 | III | III | III | · | III | III | III | III | III |
| Penicillin medicaments | 300410 | · | III | · | · | · | V | · | · | · |
| Vitamin medicaments | 300450 | III | III | III | · | · | V | · | · | · |
| Other medicaments | 300390 | III | III | · | · | III | V | · | · | · |
| Medical dressings | 300590 | · | · | · | · | IV | · | · | · | · |
| Immunological products | 300215 | III | III | III | III | II | III | III | III | III |
| Immunological products | 300214 | · | · | · | · | IV | · | · | · | · |
| Insulin medicaments | 300431 | III | III | III | · | III | III | · | · | · |
| Corticosteroid meds | 300432 | III | III | III | · | III | III | III | III | III |
| Hormone medicaments | 300439 | III | III | III | · | III | III | III | III | III |
| Antibiotics | 294190 | · | III | · | · | · | V | · | · | · |
| Organic compounds | 294200 | V | V | I | V | · | V | · | · | · |
| Heterocyclic compounds | 293339 | I | II | V | V | III | V | · | · | · |
| Pyrimidine compounds | 293359 | II | II | V | V | · | V | III | III | III |
| Nucleic acids | 293499 | II | II | V | V | · | V | · | · | · |
| Pyrazole compounds | 293319 | V | II | V | V | III | V | · | · | · |
| Imidazole compounds | 293329 | II | II | V | V | · | V | · | · | · |
| Citrate salts | 291815 | · | IV | · | · | · | · | · | · | · |
| Lactic acid | 291811 | · | IV | · | · | · | · | · | · | · |
| Herbal extracts | 130219 | · | · | · | · | I | III | · | · | · |
| Other vitamins | 293629 | · | · | · | · | · | V | · | · | · |
Import demand, duty change and action
Choose an FTA partner. Products are sorted by category, then by the size of import demand.
| Product | HS | Import demand (US$ mn) | Duty, pre → post FTA | Suggested action |
|---|---|---|---|---|
| Heterocyclic compounds | 293339 | 297 | Scale up | |
| Pyrimidine compounds | 293359 | 462 | New opportunity | |
| Nucleic acids | 293499 | 459 | New opportunity | |
| Imidazole compounds | 293329 | 193 | New opportunity | |
| Medicaments | 300490 | 13,557 | 0% | Fix supply side |
| Immunological products | 300215 | 6,667 | 0% | Fix supply side |
| Hormone medicaments | 300439 | 3,091 | 0% | Fix supply side |
| Corticosteroid meds | 300432 | 683 | 0% | Fix supply side |
| Antibiotic medicaments | 300420 | 358 | 0% | Fix supply side |
| Other medicaments | 300390 | 182 | 0% | Fix supply side |
| Insulin medicaments | 300431 | 179 | 0% | Fix supply side |
| Vitamin medicaments | 300450 | 112 | 0% | Fix supply side |
| Pyrazole compounds | 293319 | 14.12 | Defocus | |
| Organic compounds | 294200 | 13.88 | Defocus |
| Product | HS | Import demand (US$ mn) | Duty, pre → post FTA | Suggested action |
|---|---|---|---|---|
| Pyrimidine compounds | 293359 | 14,787 | New opportunity | |
| Nucleic acids | 293499 | 13,119 | New opportunity | |
| Heterocyclic compounds | 293339 | 5,255 | New opportunity | |
| Pyrazole compounds | 293319 | 4,448 | New opportunity | |
| Imidazole compounds | 293329 | 503 | New opportunity | |
| Medicaments | 300490 | 160,618 | 0% | Fix supply side |
| Immunological products | 300215 | 68,929 | 0% | Fix supply side |
| Hormone medicaments | 300439 | 15,102 | 0% | Fix supply side |
| Other medicaments | 300390 | 5,235 | 0% | Fix supply side |
| Antibiotic medicaments | 300420 | 4,671 | 0% | Fix supply side |
| Corticosteroid meds | 300432 | 4,382 | 0% | Fix supply side |
| Antibiotics | 294190 | 2,653 | 0% | Fix supply side |
| Insulin medicaments | 300431 | 2,614 | 0% | Fix supply side |
| Vitamin medicaments | 300450 | 1,494 | 0% | Fix supply side |
| Penicillin medicaments | 300410 | 1,356 | 0% | Fix supply side |
| Citrate salts | 291815 | 394 | New product | |
| Lactic acid | 291811 | 316 | New product | |
| Organic compounds | 294200 | 219 | Defocus |
| Product | HS | Import demand (US$ mn) | Duty, pre → post FTA | Suggested action |
|---|---|---|---|---|
| Organic compounds | 294200 | 37.61 | Scale up | |
| Medicaments | 300490 | 3,304 | 0% | Fix supply side |
| Immunological products | 300215 | 1,372 | 0% | Fix supply side |
| Hormone medicaments | 300439 | 789 | 0% | Fix supply side |
| Corticosteroid meds | 300432 | 201 | 0% | Fix supply side |
| Antibiotic medicaments | 300420 | 150 | 0% | Fix supply side |
| Insulin medicaments | 300431 | 87.08 | 0% | Fix supply side |
| Vitamin medicaments | 300450 | 76.38 | 0% | Fix supply side |
| Nucleic acids | 293499 | 28.23 | Defocus | |
| Heterocyclic compounds | 293339 | 10.46 | Defocus | |
| Imidazole compounds | 293329 | 4.84 | Defocus | |
| Pyrimidine compounds | 293359 | 4.55 | Defocus | |
| Pyrazole compounds | 293319 | 1.74 | Defocus |
| Product | HS | Import demand (US$ mn) | Duty, pre → post FTA | Suggested action |
|---|---|---|---|---|
| Medicaments | 300490 | 318 | 0% | Fix supply side |
| Immunological products | 300215 | 130 | 0% | Fix supply side |
| Heterocyclic compounds | 293339 | 6.65 | Defocus | |
| Nucleic acids | 293499 | 4.87 | Defocus | |
| Organic compounds | 294200 | 2.86 | Defocus | |
| Pyrimidine compounds | 293359 | 2.13 | Defocus | |
| Imidazole compounds | 293329 | 0.48 | Defocus | |
| Pyrazole compounds | 293319 | 0.17 | Defocus |
| Product | HS | Import demand (US$ mn) | Duty, pre → post FTA | Suggested action |
|---|---|---|---|---|
| Herbal extracts | 130219 | 97.79 | Scale up | |
| Immunological products | 300215 | 2,373 | New opportunity | |
| Medicaments | 300490 | 4,893 | 0% | Fix supply side |
| Hormone medicaments | 300439 | 443 | 0% | Fix supply side |
| Corticosteroid meds | 300432 | 249 | 0% | Fix supply side |
| Antibiotic medicaments | 300420 | 113 | 0% | Fix supply side |
| Insulin medicaments | 300431 | 112 | 0% | Fix supply side |
| Heterocyclic compounds | 293339 | 100 | 0% | Fix supply side |
| Other medicaments | 300390 | 35.50 | 0% | Fix supply side |
| Pyrazole compounds | 293319 | 33.49 | 0% | Fix supply side |
| Immunological products | 300214 | 93.94 | New product | |
| Medical dressings | 300590 | 91.63 | New product |
| Product | HS | Import demand (US$ mn) | Duty, pre → post FTA | Suggested action |
|---|---|---|---|---|
| Medicaments | 300490 | 766 | 0% | Fix supply side |
| Immunological products | 300215 | 194 | 0% | Fix supply side |
| Hormone medicaments | 300439 | 69.59 | 0% | Fix supply side |
| Insulin medicaments | 300431 | 38.17 | 0% | Fix supply side |
| Corticosteroid meds | 300432 | 33.43 | 0% | Fix supply side |
| Antibiotic medicaments | 300420 | 28.17 | 0% | Fix supply side |
| Herbal extracts | 130219 | 25.18 | 0% | Fix supply side |
| Nucleic acids | 293499 | 24.49 | 0% | Defocus |
| Penicillin medicaments | 300410 | 10.12 | 0% | Defocus |
| Vitamin medicaments | 300450 | 9.79 | 0% | Defocus |
| Other vitamins | 293629 | 9.30 | 0% | Defocus |
| Pyrimidine compounds | 293359 | 8.64 | 0% | Defocus |
| Other medicaments | 300390 | 5.35 | 0% | Defocus |
| Antibiotics | 294190 | 2.17 | 0% | Defocus |
| Imidazole compounds | 293329 | 1.75 | 0% | Defocus |
| Heterocyclic compounds | 293339 | 1.62 | 0% | Defocus |
| Organic compounds | 294200 | 1.35 | 0% | Defocus |
| Pyrazole compounds | 293319 | 0.28 | 0% | Defocus |
| Product | HS | Import demand (US$ mn) | Duty, pre → post FTA | Suggested action |
|---|---|---|---|---|
| Medicaments | 300490 | 44,779 | 0% | Fix supply side |
| Immunological products | 300215 | 11,025 | 0% | Fix supply side |
| Hormone medicaments | 300439 | 3,405 | 0% | Fix supply side |
| Antibiotic medicaments | 300420 | 1,147 | 0% | Fix supply side |
| Pyrimidine compounds | 293359 | 489 | 0% | Fix supply side |
| Corticosteroid meds | 300432 | 292 | 0% | Fix supply side |
| Product | HS | Import demand (US$ mn) | Duty, pre → post FTA | Suggested action |
|---|---|---|---|---|
| Medicaments | 300490 | 44,779 | 0% | Fix supply side |
| Immunological products | 300215 | 11,025 | 0% | Fix supply side |
| Hormone medicaments | 300439 | 3,405 | 0% | Fix supply side |
| Antibiotic medicaments | 300420 | 1,147 | 0% | Fix supply side |
| Pyrimidine compounds | 293359 | 489 | 0% | Fix supply side |
| Corticosteroid meds | 300432 | 292 | 0% | Fix supply side |
| Product | HS | Import demand (US$ mn) | Duty, pre → post FTA | Suggested action |
|---|---|---|---|---|
| Medicaments | 300490 | 44,779 | 0% | Fix supply side |
| Immunological products | 300215 | 11,025 | 0% | Fix supply side |
| Hormone medicaments | 300439 | 3,405 | 0% | Fix supply side |
| Antibiotic medicaments | 300420 | 1,147 | 0% | Fix supply side |
| Pyrimidine compounds | 293359 | 489 | 0% | Fix supply side |
| Corticosteroid meds | 300432 | 292 | 0% | Fix supply side |
Where the FTA gives Keralam an edge
For key products in each market: India’s current share, the competitors India will now gain a tariff edge over, and the competitors that already had duty-free access.
EU average pre-FTA duty 6%
UK average pre-FTA duty 5%
Australia average pre-FTA duty 3%
UAE average pre-FTA duty 0%
EFTA average pre-FTA duty 0%
New Zealand average pre-FTA duty 0%
Oman average pre-FTA duty 3%
Values in US$ million, 2024. Source: ITC Trade Map.
Category-wise suggested interventions
Each partner cell shows that market’s total imports from the world in US$ million, with India’s share in brackets. The colour shows the suggested category.
Pharmaceuticals
| Product | India’s exports to world (US$ mn) | UAE | Australia | EFTA | UK | Oman | EU | New Zealand |
|---|---|---|---|---|---|---|---|---|
| General retail medicines | 17899.4 | 3304.44% | 4893.49% | 44779.20% | 13556.96% | 317.913% | 160617.72% | 766.49% |
| Miscellaneous organic chemicals | 1268.5 | 37.626% | 13.53.7% | 19.619.7% | 13.910% | 2.999% | 2197% | 1.33.4% |
| Retail non-penicillin antibiotics | 1208.8 | 150.14% | 11314% | 1146.50% | 358.54% | 13.916.3% | 4670.62% | 28.211% |
| Pyridine-based chemicals | 1037.5 | 10.546% | 100.38% | 237.425.8% | 296.773% | 6.798% | 5255.47% | 1.625.6% |
| Retail penicillin medicines | 755.8 | 44.615.5% | 36.531.2% | 54.16% | 87.321.4% | 12.121% | 1356.16% | 10.18.7% |
| Non-penicillin bulk antibiotics | 640.4 | 9.415.3% | 31.924.8% | 161.50.5% | 8920% | 2.983.7% | 2652.94% | 2.10.8% |
| Complex heterocyclic/nucleic acids | 604.6 | 28.281% | 76.733.9% | 893.77.8% | 458.64% | 4.921% | 13119.23% | 24.40.3% |
| Plant-derived botanical extracts | 548.5 | 32.562% | 97.821% | 50.33.1% | 71.415.3% | 2.32% | 1203.57.8% | 25.217% |
| Botanical herbs and parts | 543.6 | 46.315% | 181.96% | 74.74.4% | 123.215.7% | 2.59% | 1429.413.8% | 14.55.5% |
| Pyrimidine-based chemicals | 523.4 | 4.540% | 17.611.1% | 489.22% | 462.42% | 2.144% | 14787.12% | 8.653.1% |
| Medical and surgical instruments | 477.2 | 413.32% | 1611.90% | 1716.30% | 2805.10% | 43.63% | 24105.70% | 310.80% |
| Cyclic amide compounds | 438.6 | 4.243% | 316% | 230.432.1% | 136.110% | 0.682% | 2627.617% | 0.90.4% |
| Retail-ready immunology products | 383.8 | 1372.41% | 2373.10% | 11024.80% | 6666.60% | 129.90% | 68928.50% | 193.70% |
Total opportunity is the import demand in the FTAs where the product falls under Categories I to III, available if the suggested action is taken. Source: ITC Trade Map.
This advisory is indicative. Duty treatment depends on the exact HS code and the rules of origin in each agreement. Check your product on the Trade Connect portal or contact the Advisory Desk before quoting a buyer.
